Private HPV Vaccine in Manchester

HPV Vaccine Consultation

Types of HPV

Human papillomavirus is a common virus that can be spread through sexual contact. Some types of HPV are considered high-risk because they can lead to the development of cervical, anal, and oropharyngeal (throat) cancers. Other types are responsible for genital warts and low-risk HPV-related conditions.

Vaccine Availability

The HPV vaccine is available in several formulations, with the most well-known being Gardasil and Cervarix. Gardasil 9, the latest version of the vaccine, protects against nine different HPV types, including those that are responsible for the majority of HPV-related cancers and genital warts.

Recommended Age

HPV vaccination is recommended for adolescents and young adults, typically starting between ages 9 and 12. The vaccine works best when administered before individuals become sexually active, as it provides protection against HPV strains that they might encounter later. Having the vaccine after sexual contact is still effective at preventing transmission of HPV strains not already encountered.

Dosage

The HPV vaccine is typically given as a series of two or three doses, depending on the age at which the series is started. The doses are usually given over a period of six months to provide optimal protection. Adults now only need a single dose.

Safety and Efficacy

Clinical trials and real-world studies have shown that the HPV vaccine is safe and highly effective in preventing infections by the targeted HPV strains. Common side effects are usually mild, such as pain or redness at the injection site.

Cancer Prevention

The primary benefit of the HPV vaccine is its role in preventing HPV-related cancers, particularly cervical cancer. By preventing the initial infection with high-risk HPV types, the vaccine significantly reduces the risk of developing these cancers.

Herd Immunity

Widespread HPV vaccination not only protects individuals who receive the vaccine but also contributes to herd immunity, reducing the overall prevalence of the virus and its associated health problems.

Gender Considerations

While the vaccine was initially recommended primarily for females, it’s now also recommended for males. HPV can cause cancers in both males and females, and vaccinating males helps reduce transmission of the virus and provides direct protection against related health issues in males as well

Continued Screening

Even with vaccination, routine cervical cancer screening is still important for women, as the vaccine does not cover all types of high-risk HPV that can cause cancer. Regular screening helps detect any abnormalities early, allowing for timely intervention.